Division of Pediatric Infectious Diseases

Pediatricians seeing increase in children with MIS-C after latest COVID surge

VUMC research contributed to first COVID-19 pill now under review

Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.

Churchwell, Creech, Wilkins among NBJ award winners

Three leaders of the Vanderbilt University Medical Center community are among the winners of the Nashville Business Journal’s 2021 Health Care Innovation awards.

Edwards among Tennessee Health Care Hall of Fame Inductees

Kathryn Edwards, MD, is among a new set of inductees into the Tennessee Health Care Hall of Fame.

Predicting blood clots before they happen in pediatric patients

Monroe Carell Jr. Children’s Hospital at Vanderbilt has launched a study to determine the impact of a predictive model for identifying pediatric patients at risk for developing blood clots or venous thromboembolisms (VTEs).

The new multisystem inflammatory syndrome in children clinic team includes, from left, Sophie Katz, MD, MPH, Natasha Halasa, MD, MPH, Anna Patrick, MD, PhD, and David Parra, MD.

Multisystem inflammatory syndrome in children (MIS-C) clinic opens at Monroe Carell Jr. Children’s Hospital at Vanderbilt

Children who have experienced the rare and potentially life-threatening multisystem inflammatory syndrome in children (MIS-C), which can develop within four weeks of exposure to the virus that causes COVID-19, are being followed closely in a multidisciplinary clinic at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

1 2 3 4 5 6 11